menu
    • menu
    [{"orgOrder":0,"company":"Dark Blue Therapeutics","sponsor":"Amgen Inc","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2026","type":"Acquisition","leadProduct":"DBT 3757","moa":"MLLT1\/3","graph1":"Oncology","graph2":"IND Enabling","graph3":"Dark Blue Therapeutics","amount2":0.83999999999999997,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Oncology","amount2New":0.83999999999999997,"dosageForm":"Undisclosed","sponsorNew":"Dark Blue Therapeutics \/ Amgen Inc","highestDevelopmentStatusID":"5","companyTruncated":"Dark Blue Therapeutics \/ Amgen Inc"}]

    Find Clinical Drug Pipeline Developments & Deals by Dark Blue Therapeutics

    Menu

    Dark Blue Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Dark Blue Therapeutics

                            United Kingdom arrow
                            VMX
                            Not Confirmed

                            Dark Blue Therapeutics

                            United Kingdom arrow
                            VMX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : DBT 3757

                            Therapeutic Area : Oncology

                            Study Phase : IND Enabling

                            Sponsor : Amgen Inc

                            Deal Size : $840.0 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Amgen Acquires Dark Blue Therapeutics for up to $840 Million

                            Details : Through the acquisition of DBT 3757, the deal aims to advance treatment options for ACUTE MYELOID LEUKEMIA by targeting MLLT1/3.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            January 06, 2026

                            Lead Product(s) : DBT 3757

                            Therapeutic Area : Oncology

                            Highest Development Status : IND Enabling

                            Sponsor : Amgen Inc

                            Deal Size : $840.0 million

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.